Dosing frequency and medication adherence in chronic disease
- PMID: 22971206
- PMCID: PMC10438207
- DOI: 10.18553/jmcp.2012.18.7.527
Dosing frequency and medication adherence in chronic disease
Abstract
Background: Prior research has shown a decrease in medication adherence as dosing frequency increases; however, meta-analyses have not been able to demonstrate a significant inverse relationship between dosing frequency and adherence when comparing twice-daily versus once-daily dosing.
Objective: To determine the effect of scheduled dosing frequency on medication adherence in patients with chronic diseases.
Methods: A systematic literature search of Medline and Embase from January 1986 to December 2011 and a hand search of references were performed to identify eligible studies. Randomized and observational studies were included if they utilized a prospective design, assessed adult patients with chronic diseases, evaluated scheduled oral medications taken 1 to 4 times daily, and measured medication adherence for at least 1 month using an electronic monitoring device. Manual searches of reference sections of identified studies and systematic reviews were also performed to find other potentially relevant articles. Standard definitions for medication taking, regimen, and timing adherence were used and evaluated. Studies were pooled using a multivariate linear mixed-model method to conduct meta-regression accounting for both random and fixed effects, weighted by the inverse of the variance of medication adherence.
Results: Fifty-one studies, comprising 65, 76, and 47 dosing frequency arms for the taking, regimen, and timing adherence endpoints were included. Unadjusted adherence estimates were highest when the least stringent definition, taking adherence, was used (range for dosing frequencies: 80.1%-93.0%) and lowest when the most stringent definition, timing adherence, was used (range for dosing frequencies: 18.8%-76.9%). In multivariate meta-regression analyses, the adjusted weighted mean percentage adherence rates for all regimens dosed more frequently than once per day were significantly lower compared with once-daily regimens (for 2-times, 3-times, and 4-times daily regimens, respectively: differences for taking adherence: -6.7%, -13.5%, and -19.2%; regimen adherence: -13.1%, -24.9%, and -23.1%; and timing adherence: -26.7%, -39.0%, and -54.2%).
Conclusion: Patients with chronic diseases appear to be more adherent with once-daily compared with more frequently scheduled medication regimens. The use of more stringent definitions of adherence magnified these findings.
Copyright © 2012, Academy of Managed Care Pharmacy. All rights reserved.
Similar articles
-
Effect of dosing frequency on chronic cardiovascular disease medication adherence.Curr Med Res Opin. 2012 May;28(5):669-80. doi: 10.1185/03007995.2012.677419. Epub 2012 Apr 5. Curr Med Res Opin. 2012. PMID: 22429067
-
Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis.Int J Cardiol. 2016 Aug 1;216:104-9. doi: 10.1016/j.ijcard.2016.04.082. Epub 2016 May 1. Int J Cardiol. 2016. PMID: 27144286
-
A systematic review of the associations between dose regimens and medication compliance.Clin Ther. 2001 Aug;23(8):1296-310. doi: 10.1016/s0149-2918(01)80109-0. Clin Ther. 2001. PMID: 11558866
-
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Jul 2;21(1):604. doi: 10.1186/s13063-020-04543-4. Trials. 2020. PMID: 32616067 Free PMC article.
-
Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence.Europace. 2015 Apr;17(4):514-23. doi: 10.1093/europace/euu311. Epub 2015 Feb 17. Europace. 2015. PMID: 25694538 Review.
Cited by
-
Medication Dosing Schedules, Medication Knowledge, and Dosing Errors of Adults Taking Complex Drug Regimens.J Health Care Poor Underserved. 2023;34(1):192-207. doi: 10.1353/hpu.2023.0013. J Health Care Poor Underserved. 2023. PMID: 37464489 Free PMC article.
-
Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs.Patient Prefer Adherence. 2014 Nov 18;8:1611-7. doi: 10.2147/PPA.S70651. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 25429206 Free PMC article.
-
Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia.Adv Ther. 2017 Aug;34(8):1876-1896. doi: 10.1007/s12325-017-0586-8. Epub 2017 Jul 17. Adv Ther. 2017. PMID: 28717862 Free PMC article. Review.
-
Factors predicting medication adherence among Omani patients with chronic diseases through a multicenter cross-sectional study.Sci Rep. 2023 May 1;13(1):7067. doi: 10.1038/s41598-023-34393-4. Sci Rep. 2023. PMID: 37127692 Free PMC article.
-
Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial.Respir Res. 2019 Dec 3;20(1):273. doi: 10.1186/s12931-019-1219-3. Respir Res. 2019. PMID: 31796013 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical